PSX
44
5
AIG
56
2
KLAC
63
5
WYNN
41
3
HPE
12
2
JNPR
43
-3
ADBE
51
2
KMI
50
6
EXPE
61
5
WMB
64
2
CNX
63
2
CRM
47
2
EMN
72
3
XYL
64
10
CINF
51
-2
BAC
48
10
MCO
73
2
C
46
2
VNO
59
4
NI
53
3
PSX
44
5
AIG
56
2
KLAC
63
5
WYNN
41
3
HPE
12
2
JNPR
43
-3
ADBE
51
2
KMI
50
6
EXPE
61
5
WMB
64
2
CNX
63
2
CRM
47
2
EMN
72
3
XYL
64
10
CINF
51
-2
BAC
48
10
MCO
73
2
C
46
2
VNO
59
4
NI
53
3
Financhill
Back

Innoviva Quote, Financials, Valuation and Earnings

My #1 Coin is...

All the details are on the next page.
Buy
59

INVA
Innoviva

Last Price:
15.19
Seasonality Move:
1.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!

Innoviva Price Quote

$15.19
-0.01 (-1.17%)
(Updated: May 4, 2024 at 4:15 AM ET)

Innoviva Key Stats

Buy
59
Innoviva (INVA) is a Buy
Day range:
$15.13 - $15.63
52-week range:
$11.55 - $16.87
Dividend yield:
0%
P/E ratio:
6.91
P/S ratio:
4.00
P/B ratio:
1.42%
Volume:
428.5K
Avg. volume:
610.9K
1-year change:
31.83%
Market cap:
$961.1M
Revenue:
$310.5M
EPS:
$2.18

How Much Does Innoviva Make?

  • How Much Are Innoviva's Sales Annually?
    INVA Revenues are $310.5M
  • How Much Profit Does Innoviva's Make A Year?
    INVA net income is $179.7M

Is Innoviva Growing As A Company?

  • What Is Innoviva's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.3%
  • What Is Innoviva's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Innoviva Stock Price Performance

  • Did Innoviva Stock Go Up Last Month?
    Innoviva share price went up by 2.63% last month
  • Did INVA's Share Price Rise Over The Last Year?
    INVA share price rose by 31.83% over the past 1 year

What Is Innoviva 52-Week High & Low?

  • What Is Innoviva’s 52-Week High Share Price?
    Innoviva has traded as high as $16.87 over the past 52 weeks
  • What Is Innoviva’s 52-Week Low Share Price?
    Innoviva has traded as low as $11.55 over the past 52 weeks

Innoviva Price To Free Cash Flow

  • Is Innoviva Stock Overvalued?
    Innoviva is trading at a price to free cash flow ratio of 8.82
  • Is Innoviva Stock Undervalued?
    Innoviva EV to Free Cash Flow ratio is 8.63
  • What Is Innoviva’s Price Earnings Growth Ratio?
    INVA PEG ratio is 0.94
  • Is Innoviva Trading At A Premium To Earnings?
    Innoviva EV to EBIT ratio is 5.69

Is It Risky To Buy Innoviva?

  • How Much Debt Does Innoviva Have?
    Total long term debt quarterly is $446.2M
  • How Much Cash Does Innoviva Have?
    Cash and short term investments quarterly total is $193.5M
  • What Is Innoviva’s Book Value Per Share?
    Book value per share is 10.66

Is Innoviva Cash Flow Positive?

  • What Is INVA Cash Flow From Operations?
    Cash flow from operations (TTM) is $141.1M
  • What Is Innoviva’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$171.8M
  • What Is Innoviva’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$66.8M

Innoviva Return On Invested Capital

  • Is Management Doing A Good Job?
    INVA return on invested capital is 16.93%
  • What Is Innoviva Return On Assets?
    ROA measures how assets are converting to revenues and is 15.2%
  • What Is INVA Return On Equity?
    ROE is a measure of profitability and is 30.11%

Innoviva Earnings Date & Stock Price

  • What Is Innoviva's Stock Price Today?
    A single share of INVA can be purchased today for 15.20
  • What Is Innoviva’s Stock Symbol?
    Innoviva trades on the nasdaq under the ticker symbol: INVA
  • When Is Innoviva’s Next Earnings Date?
    The next quarterly earnings date for Innoviva is scheduled on May 9, 2024
  • When Is INVA's next ex-dividend date?
    Innoviva's next ex-dividend date is May 21, 2020
  • How To Buy Innoviva Stock?
    You can buy Innoviva shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Innoviva Competitors

  • Who Are Innoviva's Competitors?
    Below is a list of companies who compete with Innoviva or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Innoviva Dividend Yield

Data Unavailable

Innoviva Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 230.44%
Revenue: 30.45% 13.67%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 15.00
Downside from Last Price: -1.32%

Major Shareholders

  • How many INVA shares are owned by institutional investors?
    104.4M INVA shares are owned by institutional investors
  • How many INVA shares are owned by insiders?
    7.7M INVA shares are owned by insiders